On September 30, President Trump signed into law a Continuing Resolution (CR), which would provide flat funding for federal agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI), through November 21, 2019.
Although the CR keeps the government operating, short-term spending bills make it difficult for federal agencies like the NIH – as well as the institutions and scientists it supports – to effectively plan for research projects.
ASCO applauds action taken recently by the Senate Appropriations Committee to pass a funding bill that included a $3 billion increase for NIH and encourages Congress to take action to include the highest increase possible in a full Fiscal Year (FY) 2020 funding package. A funding increase for NIH and NCI is critical to keep up with the rate of biomedical inflation and deliver on the promise of today’s research.
Urge Congress to pass a funding bill that invests in federally funded cancer research.